Umlobi: William Ramirez
Usuku Lokudalwa: 23 Usepthemba 2021
Ukuvuselela Usuku: 21 Ujuni 2024
Anonim
Uzipho lukaDeveli - Umuthi
Uzipho lukaDeveli - Umuthi

-Delile

Uzipho lukaDeveli umuthi. Igama lezitshalo, i-Harpagophytum, lisho ukuthi "isitshalo sokuxhuma" ngesiGreki. Lesi sitshalo sithola igama laso ngokuvela kwesithelo saso, esigcwele izingwegwe ezihloselwe ukunamathisela ezilwaneni ukusabalalisa imbewu. Izimpande nezilimo eziyizigaxa zesitshalo zisetshenziselwa ukwenza umuthi.

Uzipho lukaDeveli lusetshenziselwa ubuhlungu beqolo, i-osteoarthritis, i-rheumatoid arthritis (RA), nezinye izimo, kodwa abukho ubufakazi obuhle besayensi obusekela lokhu kusetshenziswa.

Isifo seCoronavirus 2019 (COVID-19): Abanye ochwepheshe baxwayisa ukuthi uzipho lukadeveli lungaphazamisa impendulo yomzimba ngokumelene ne-COVID-19. Ayikho idatha eqinile yokuxhasa lesi sexwayiso. Kepha futhi ayikho idatha enhle yokuxhasa usebenzisa uzipho lukaSathane lwe-COVID-19.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze ISICELO SIKADeveli zimi kanje:


Kungenzeka kusebenze ...

  • Ukuhlungu obusemhlane. Ukuthatha uzipho lukaSathane ngomlomo kubonakala kunciphisa izinhlungu eziseqolo. Uzipho lukaDeveli lubonakala lusebenza kanye neminye imishanguzo engewona ama-steroidal anti-inflammatory (NSAIDs).
  • I-osteoarthritis. Ukuthatha uzipho lukaDeveli kuphela, nezinye izithako, noma kanye nezidakamizwa ezingezona ukuvuvukala (ama-NSAID) kubonakala kusiza ukunciphisa izinhlungu ezihlobene ne-osteoarthritis. Obunye ubufakazi busikisela ukuthi uzipho lukadeveli lusebenza mayelana ne-diacerhein (umuthi osebenza kancane we-osteoarthritis ongatholakali e-U.S.) Wokuthuthukisa ubuhlungu be-osteoarthritis enqeni nasemadolweni ngemuva kwamasonto ayi-16 okwelashwa. Abanye abantu abathatha uzipho lukadeveli babonakala bekwazi ukwehlisa umthamo wama-NSAID abawadingayo ukuze kudambiswe izinhlungu.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Isifo samathambo (RA). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha uzipho lukadeveli ngomlomo kungahle kungathuthukisi iRA.
  • Ukuqina kwemithambo yegazi (i-atherosclerosis).
  • Ubuhlungu besifuba esibucayi lapho uphefumula (ubuhlungu besifuba se-pleuritic).
  • I-Fibromyalgia.
  • Gout.
  • I-cholesterol ephezulu.
  • Ukuphelelwa isifiso sokudla.
  • Ubuhlungu bemisipha.
  • Migraine.
  • Ukuqunjelwa (i-dyspepsia).
  • Imfiva.
  • Izikhukhula zokuya esikhathini (i-dysmenorrhea).
  • Izikhathi ezingajwayelekile.
  • Ubunzima ngesikhathi sokubeletha.
  • Ukuvuvukala (ukuvuvukala) kwethenda (tendinitis).
  • Ukungezwani komzimba.
  • Isifo sezinso nesinye.
  • Ukupholisa amanxeba, lapho kufakwa esikhunjeni.
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala uzipho lukaDeveli ngalokhu kusetshenziswa.

Uzipho lukaDeveli luqukethe amakhemikhali angahle anciphise ukuvuvukala nokuvuvukala nobuhlungu obuvelayo.

Lapho ithathwa ngomlomo: Uzipho lukaDeveli OKUNGENZEKA UKUPHEPHA kubantu abaningi abadala lapho bethathwe kuze kube unyaka. Umphumela ovame kakhulu uhudo. Eminye imiphumela emibi ingahle ifake isicanucanu, ukugabha, ubuhlungu besisu, ikhanda elibuhlungu, ukukhala ezindlebeni, ukungathandi ukudla, nokulahlekelwa ukunambitha. Uzipho lukaDeveli lungadala ukungezwani kwesikhumba, izinkinga zokuya esikhathini, nezinguquko kumfutho wegazi. Le micimbi ayijwayelekile.

Akukho mininingwane ethembekile yokwazi ukuthi uzipho lukaDeveli luphephile yini uma luthathwe isikhathi esingaphezu konyaka.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele oluthembekile lokwazi ukuthi uzipho lukaDeveli luphephile yini noma yini imiphumela emibi engaba yiyo.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa: Uzipho lukaDeveli MHLAWUMBI ANGIPHEPHILE lapho isetshenziswa ngesikhathi sokukhulelwa. Kungalimaza umbungu okhulayo. Gwema ukusebenzisa.

Ukuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa lokwazi ukuthi uzipho lukaDeveli luphephile yini ukusetshenziswa uma uncelisa. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Izinkinga zenhliziyo, umfutho wegazi ophakeme, umfutho ophansi wegazi: Uzipho lukaDeveli lungathinta ukushaya kwenhliziyo, ukushaya kwenhliziyo, nomfutho wegazi. Kungalimaza abantu abanezinkinga zenhliziyo nohlelo lokujikeleza kwegazi. Uma unesinye salezi zimo, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokuqala uzipho lukaDeveli.

Isifo sikashukela: Uzipho lukaDeveli lungehlisa amazinga kashukela egazini.Ukuyisebenzisa kanye nemithi eyehlisa ushukela wegazi kungadala ukuthi ushukela wegazi wehle kakhulu. Bheka amazinga eglucose egazi eduze. Umhlinzeki wakho wezokunakekelwa kwempilo angadinga ukulungisa umthamo wakho wemithi yesifo sikashukela.

Amatshe amatshe amade: Uzipho lukaDeveli lungakhuphula ukukhiqizwa kwe-bile. Lokhu kungaba yinkinga kubantu abanezinyongo. Gwema ukusebenzisa uzipho lukaSathane.

Amazinga aphansi e-sodium emzimbeni: Uzipho lukaDeveli lunganciphisa amazinga e-sodium emzimbeni. Lokhu kungazenza zibe zimbi izimpawu kubantu asebevele benamazinga aphansi e-sodium.

Isifo se-Peptic ulcer (PUD): Njengoba uzipho lukaDeveli lungakhuphula ukukhiqizwa kwama-acid esiswini Lokhu kungalimaza abantu abanezilonda esiswini. Gwema ukusebenzisa uzipho lukaSathane.

Maphakathi
Qaphela ngale nhlanganisela.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C19 (CYP2C19))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Uzipho lukaDeveli lungahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha uzipho lukaDeveli kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha ukukhuluma ngozipho lukadeveli kumhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eguqulwa isibindi ifaka i-omeprazole (Prilosec), i-lansoprazole (i-Prevacid), ne-pantoprazole (i-Protonix); diazepam (Valium); i-carisoprodol (iSoma); i-nelfinavir (i-Viracept); nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Uzipho lukaDeveli lungahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha uzipho lukaDeveli kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha ukukhuluma ngozipho lukadeveli kumhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eguqulwa isibindi ifaka phakathi i-diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), ne-piroxicam (Feldene); i-celecoxib (Celebrex); i-amitriptyline (u-Elavil); i-warfarin (i-Coumadin); i-glipizide (iGlucotrol); losartan (Cozaar); nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 3A4 (CYP3A4))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Uzipho lukaDeveli lungahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha uzipho lukaDeveli kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha uzipho lukaSathane, khuluma nomhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eshintshwe yisibindi ifaka i-lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), neminye eminingi.
I-Warfarin (Coumadin)
I-Warfarin (i-Coumadin) isetshenziselwa ukunciphisa ukubamba kwegazi. Uzipho lukaDeveli lungakhuphula imiphumela ye-warfarin (i-Coumadin) futhi lukhulise namathuba okulimala nokopha. Qiniseka ukuthi uhlolwa igazi lakho njalo. Umthamo we-warfarin yakho (i-Coumadin) ungadinga ukuguqulwa.
Okuncane
Qaphela ngale nhlanganisela.
Imithi ihanjiswe ngamaphampu kumaseli (ama-P-glycoprotein Substrates)
Eminye imithi ihanjiswa ngamaphampu kumaseli. Uzipho lukaDeveli lungenza la mapampu angasebenzi kahle futhi kwandise ukuthi eminye imithi ingena emzimbeni kangakanani. Lokhu kungakhuphula imiphumela emibi yemithi ethile.

Eminye imishanguzo ehanjiswa yilamaphampu ifaka phakathi i-etoposide, paclitaxel, vinblastine, vincristine, vindesine, ketoconazole, itraconazole, amprenavir, indinavir, nelfinavir, saquinavir, cimetidine, ranitidine, diltiazem, verapamil, corticosterosidi Allegra), cyclosporine, loperamide (Imodium), quinidine, nabanye.
Imithi eyehlisa isisu i-acid (H2-blockers)
Uzipho lukaDeveli lungakhuphula i-asidi esiswini. Ngokwandisa i-asidi esiswini, uzipho lukaDeveli lunganciphisa ukusebenza kweminye imishanguzo eyehlisa isisu i-asidi, ebizwa nge-H2-blockers.

Eminye imishanguzo eyehlisa i-asidi esiswini ifaka phakathi i-cimetidine (Tagamet), i-ranitidine (i-Zantac), i-nizatidine (i-Axid), ne-famotidine (i-Pepcid).
Imithi eyehlisa isisu i-acid (Proton pump inhibitors)
Uzipho lukaDeveli lungakhuphula i-asidi esiswini. Ngokwandisa i-asidi esiswini, uzipho lukaDeveli lunganciphisa ukusebenza kwemithi esetshenziselwa ukwehlisa isisu i-asidi, ebizwa nge-proton pump inhibitors.

Eminye imishanguzo eyehlisa isisu i-asidi ifaka i-omeprazole (Prilosec), i-lansoprazole (i-Prevacid), i-rabeprazole (i-Aciphex), i-pantoprazole (i-Protonix), ne-esomeprazole (Nexium).
Akukho ukuxhumana okwaziwayo ngamakhambi nezengezo.
Akukho ukuxhumana okwaziwayo nokudla.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

NGOMLOMO:
  • Okwe-osteoarthritis: 2-2.6 amagremu we-devil's claw akhiphiwe athathwe ngemithamo emithathu ehlukanisiwe nsuku zonke izinyanga ezifika kwezine. Umkhiqizo ohlanganisiwe othize ohlinzeka ngo-600 mg ka-devil's claw, u-400 mg we-turmeric, kanye no-300 mg we-bromelain uthathwe ama-2-3 kathathu nsuku zonke kuze kube izinyanga ezi-2. Umkhiqizo othile wenhlanganisela (iRosaxan, medAgil Gesundheitsgesellschaft mbH) equkethe uzipho lukaDeveli, inhlabamkhosi ebabayo, inyonga yenyuka, kanye novithamini D othathwe ngomlomo njengoba i-40 mL nsuku zonke isetshenziswe amasonto ayi-12.
  • Ngezinhlungu emuva: U-0.6-2.4 amagremu wesikhombi sikaDeveli uzipho uthathwe nsuku zonke, imvamisa ngemithamo ehlukanisiwe, unyaka owodwa.
Devils Claw, Devil's Claw Root, Garra del Diablo, Grapple Plant, Griffe du Diable, Harpagophyti Radix, Harpagophytum, Harpagophytum procumbens, Harpagophytum zeyheri, Racine de Griffe du Diable, Racine de Windhoek, Teufelskrallenwurzel, Uncaria.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. ICarvalho RR, iCDadadel CD, iCortez AF, iValviesse VR, iVianna PF, iCorrea BB. UJ Bras Nefrol. 2017 Mar; 39: 79-81. Buka okungaqondakali.
  2. Okuningi M, Gruenwald J, Pohl U, Uebelhack R. I-Rosa canina - Urtica dioica - Inhlanganisela yeHarpagophytum procumbens / zeyheri inciphisa kakhulu izimpawu ze-gonarthritis esifundweni esilawulwa ngokungahleliwe, esilawulwa yi-placebo esilawulwa izimpumputhe. UPlanta Med. 2017 Disemba; 83: 1384-91. Buka okungaqondakali.
  3. IMahomed IM, Ojewole JAO. Umphumela ofana ne-oxygen we-Harpagophytum procumbens [Pedaliacae] impande yesibili ekhishwa i-aqueous esibelethweni esihlukanisiwe segundane. I-Afr J Trad CAM 2006; 3: 82-89.
  4. UCuspidi C, uSala C, uTadic M, et al. Umfutho wegazi ophakeme obangelwa yiHarpagophytum procumbens (udeveli uzipho): umbiko wecala. J Clin Hypertens (Greenwich) 2015; 17: 908-10. Buka okungaqondakali.
  5. UConrozier T, uMathieu P, uBonjejean M, et al. Inxanxathela yama-ejenti amathathu emvelo alwa nokuvuvukala ahlinzeka ukukhululeka kobuhlungu be-osteoarthritis. I-Altern Ther Health Med. 2014; 20 Isengezo 1: 32-7.
  6. UChrubasik S, uSporer F, noWink M. [Okuqukethwe kweHarpagoside kokukhishwa okomile okuyimpuphu okwehlukene kusuka kuHarpagophytum procumbens]. UForsch Komplmentarmed 1996; 3: 6-11.
  7. UChrubasik S, Schmidt A, uJunck H, no-et al. [Ukusebenza kahle kanye nomnotho we-Harpagophytum ekhishwe ekwelapheni izinhlungu ezibuhlungu ezisezingeni eliphansi - imiphumela yokuqala yocwaningo lweqembu lokwelashwa]. UForsch Komplementarmed 1997; 4: 332-336.
  8. IChrubasik S, Model A, Black A, kanye et al. Ucwaningo lomqhubi wendiza oluyimpumputhe olungahleliwe ngokuqhathanisa iDoloteffin® neVioxx® ekwelapheni izinhlungu ezisezingeni eliphansi. I-Rheumatology 2003; 42: 141-148.
  9. UBiller, A. Ergebnisse sweier randomisieter kontrollierter. I-Phyto-pharmaka 2002; 7: 86-88.
  10. Schendel, U. Ukwelashwa kwesifo samathambo: Funda nge-Devil Claw extract [ngesiJalimane]. UDer Kassenarzt 2001; 29/30: 2-5.
  11. Usbeck, C. Teufelskralle: Uzipho lukaDeveli: Ukwelashwa kobuhlungu obungapheli [ngesiJalimane]. I-Arzneimittel-Iforamu 2000; 3: 23-25.
  12. Rutten, S. and Schafer, I. Einsatz der afrikanischen Teufelskralle [Allya] bei Erkrankungen des Stutz unde Bewegungsapparates. Umshayeli we-Ergebnisse Anwendungscbeobachtung Acta Biol 2000; 2: 5-20.
  13. UPinget, M. noLecomte, A. Umphumela weHarpagophytum Arkocaps ku-rheumatism ewohlokayo [ngesiJalimane]. I-Naturheilpraxis 1997; 50: 267-269.
  14. URibbat JM noSchakau D. Behandluing chronisch aktivierter Schmerzen am Bewegungsapparat. UNaturaMed 2001; 16: 23-30.
  15. ULoew D, Schuster O, noMöllerfeld J. Stabilität und biopharmazeutische Qualität. IVoraussetzung für Bioverfügbarkeit von Harpagophytum procumbens. Ku: Loew D noRietbrock N. Phytopharmaka II. Forschung und klinische Anwendung. IDarmstadt: I-Forschung und klinische Anwendung; 1996.
  16. UTunmann P noBauersfeld HJ. I-weber weitere Inhaltsstoffe der Wurzel von Harpagophytum iphatha i-DC. I-Arch Pharm (Weinheim) 1975; 308: 655-657.
  17. UFicarra P, Ficarra R, Tommasini A, no-al. [Ukuhlaziywa kwe-HPLC kwesidakamizwa emithini yendabuko: I-Harpagophytum yenza i-DC. Mina]. IBoll Chim Farm 1986; 125: 250-253.
  18. UTunmann P noLux R. Zur Kenntnis der Inhaltsstoffe aus der Wurzel von Harpagophytum ubusa i-DC. I-DAZ 1962; 102: 1274-1275.
  19. I-Kikuchi T. Ama-glucosides amasha we-iridoid avela ku-Harpagophytum procumbens. UChem Pharm Bull 1983; 31: 2296-2301.
  20. UZimmermann W. Pflanzliche Bitterstoffe e-der Gastroenterologie. UZ Allgemeinmed 1976; 23: 1178-1184.
  21. UVan Haelen M, van Haelen-Fastré R, uSamaey-Fontaine J, no-al. Izici zebotanique, umthethosisekelo chimique et activité pharmacologique d'Harpagophytum procumbens. I-Phytotherapy 1983; 5: 7-13.
  22. UChrubasik S, Zimpfer C, Schutt U, no-al. Ukusebenza kwe-Harpagophytum procumbens ekwelapheni ubuhlungu obubuhlungu obuphansi emuva. I-Phytomedicine 1996; 3: 1-10.
  23. UChrubasik S, uSporer F, uWink M, no-et al. Zum wirkstoffgehalt ku arzneimitteln aus harpagophytum procumbens. UForsch Komplementärmed 1996; 3: 57-63.
  24. UChrubasik S, Sporer F, noWink M. [Okuqukethwe kokwenza okusebenzayo kumalungiselelo wetiye avela eHarpagophytum procumbens]. UForsch Komplementarmed 1996; 3: 116-119.
  25. ULangmead L, uDawson C, uHawkins C, no-al. Imiphumela ye-antioxidant yemithi yokwelapha esetshenziswa yiziguli ezinesifo samathumbu esivuthayo: isifundo se-in vitro. I-Aliment Pharmacol Ther 2002; 16: 197-205.
  26. IBhattacharya A neBhattacharya SK. Umsebenzi we-anti-oxidative we-Harpagophytum procumbens. UBr J Phytother 1998; 72: 68-71.
  27. USchmelz H, uHaemmerle HD, noSpringorum HW. I-Analgetische Wirksamkeit eines Teufels-krallenwurzel-Extraktes bei verschiedenen chronisch-degenerativen Gelenkerkrankungen. Ku: Chrubasik S noWink M. Rheumatherapie mit Phytopharmaka. IStuttgart: AmaHippokrate; 1997.
  28. UFrerick H, uBiller A, noSchmidt U. Stufenschema bei Coxarthrose. UDer Kassenarzt 2001; 5: 41.
  29. USchrüffer H. Salus Teufelskralle-Tabletten. I-Ein Fortschritt in der nichtsteroidalen antirheumatischen Therapie. Ukushicilelwa kukaDie Medizinische 1980; 1: 1-8.
  30. I-Pinget M ne-Lecompte A. Etude des effets de I’harpagophytum en rhumatologie dégénérative. 37 Le magazine 1990;: 1-10.
  31. ILecomte A neCosta JP. I-Harpagophytum dans l'arthrose: Etude en double insu contre placebo. Le Magazine 1992; 15: 27-30.
  32. UGuyader M. Les utshala ama-antirhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d'Harpagohytum procumbens DC chez 50 patients arthrosiques suivis en service hospitaler [Ukuxoshwa]. I-Universite Pierre et Marie Curie, ngo-1984.
  33. Belaiche P. Etude clinique de 630 cas d'artrose traites par le nebulisat aqueux d'Harpagophytum procumbens (Radix). I-Phytotherapy 1982; 1: 22-28.
  34. UChrubasik S, Fiebich B, uMnyama A, no-et al. Ukwelapha izinhlungu ezisezingeni eliphansi ngokukhishwa kwe-Harpagophytum procumbens evimbela ukukhishwa kwe-cytokine. I-Eur J Anaesthesiol 2002; 19: 209.
  35. UChrubasik S no-Eisenberg E. Ukwelashwa kobuhlungu bamathambo ngomuthi weKampo eYurophu. Umtholampilo Wezinhlungu 1999; 11: 171.
  36. UJadot G noLecomte A. Ukwenza umsebenzi wokulwa ne-inflammatoire d'Harpagophytum procumbens DC. ILyon Mediteranee Med Sud-Est 1992; 28: 833-835.
  37. UFontaine, J., Elchami, A. A., Vanhaelen, M., noVanhaelen-Fastre, R. [Ukuhlaziywa kwezinto eziphilayo kweHarpagophytum procumbens DC II. Ukuhlaziywa kwemithi yemiphumela ye-harpagoside, i-harpagide ne-harpagogenine ku-ileinea ye-pig-pig ileum (inguqulo yombhali)]. UJ Pharm Belg. 1981; 36: 321-324. Buka okungaqondakali.
  38. Eichler, O. noKoch, C. [Umphumela we-antiphlogistic, analgesic kanye ne-spasmolytic we-harpagoside, i-glycoside evela empandeni ye-Harpagophytum procumbens DC]. Arzneimittelforschung. Ngo-1970; 20: 107-109. Buka okungaqondakali.
  39. U-Occhiuto, F., Circosta, C., Ragusa, S., Ficarra, P., noCosta, uDe Pasquale. Isidakamizwa esisetshenziswa emithini yendabuko: IHarpagophytum procumbens DC. IV. Imiphumela kwamanye amalungiselelo emisipha angawodwa. J Ethnopharmacol. 1985; 13: 201-208. Buka okungaqondakali.
  40. U-Erdos, A., Fontaine, R., Friehe, H., Durand, R., noPoppinghaus, T. [Umnikelo ekhemisi nakwezobuthi zezinto ezihlukile ezikhishwe kanye ne-harpagosid evela ku-Harpagophytum procumbens DC]. UPlanta Med 1978; 34: 97-108. Buka okungaqondakali.
  41. Brien, S., Lewith, G. T., noMcGregor, G. Devil's Claw (Harpagophytum procumbens) njengokwelapha i-osteoarthritis: ukubuyekezwa kokusebenza nokuphepha. J Altern Complement Med 2006; 12: 981-993. Buka okungaqondakali.
  42. UGrant, L., McBean, D. E., Fyfe, L., noWarnock, A. M. Ukubuyekezwa kwezenzo zebhayoloji nezingahle zenziwe zokwelashwa kwe-Harpagophytum procumbens. I-Phytother Res 2007; 21: 199-209. Buka okungaqondakali.
  43. Ameye, L. G. noCee, W. S. Osteoarthritis nokudla okunempilo. Kusuka kuma-nutraceuticals kuya ekudleni okusebenzayo: ukubuyekezwa okuhlelekile kobufakazi besayensi. I-Arthritis Res Ther 2006; 8: R127. Buka okungaqondakali.
  44. Teut, M. and Warning, A. [Bone metastases in breast carcinoma]. I-Forsch Komplement. Meded 2006; 13: 46-48. Buka okungaqondakali.
  45. UKundu, J. K., Mossanda, K. S., Na, H.K, noSurh, Y. J. Imiphumela yokuvimbela ukukhishwa kweSutherlandia frutescens (L.) R. Br. futhi iHarpagophytum iphatha i-DC. kunkulumo ye-COX-2 eyenziwe nge-phorbol ester esikhunjeni segundane: i-AP-1 ne-CREB njengezinjongo ezingase zibe phezulu. Umdlavuza Lett. 1-31-2005; 218: 21-31. Buka okungaqondakali.
  46. UChrubasik, S. Isengezo esithombeni se-ESCOP ku-Harpagophytum procumbens. I-Phytomedicine. 2004; 11 (7-8): 691-695. Buka okungaqondakali.
  47. UKaszkin, M., Beck, KF, Koch, E., Erdelmeier, C., Kusch, S., Pfeilschifter, J., noLoew, D. Ukwehliswa komthetho kwenkulumo ye-iNOS kumaseli wama-rat mesangial ngokukhishwa okukhethekile kwe-Harpagophytum procumbens kuvela imiphumela encike ku-harpagoside futhi ezimele. I-Phytomedicine. 2004; 11 (7-8): 585-595. Buka okungaqondakali.
  48. UNa, H. K., Mossanda, K. S., Lee, J. Y., noSurh, Y. J. Ukuvinjelwa kwenkulumo ye-phorbol ester eyenziwe nge-COX-2 ngezinye zezitshalo ezidliwayo zase-Afrika. Ama-Biofactors 2004; 21 (1-4): 149-153. Buka okungaqondakali.
  49. I-Chrubasik, S. [Uzipho lukaDeveli lukhipha njengesibonelo sokusebenza kwe-analgesics yamakhambi]. I-Orthopade 2004; 33: 804-808. Buka okungaqondakali.
  50. I-Schulze-Tanzil, G., Hansen, C., ne-Shakibaei, M. [Umphumela we-Harpagophytum ukhipha i-DC ekhishwa kuma-metrix metalloproteinases kuma-chondrocyte womuntu ku-vitro]. Arzneimittelforschung. 2004; 54: 213-220. Buka okungaqondakali.
  51. UChrubasik, S., Conradt, C., noRoufogalis, B. D. Ukuphumelela kokukhishwa kweHarpagophytum nokusebenza komtholampilo. I-Phytother.Res. 2004; 18: 187-189. Buka okungaqondakali.
  52. UBoje, K., Lechtenberg, M., noNahrstedt, A. Ama-glycosides amasha naziwa nge-iridoid- ne-phenylethanoid avela ku-Harpagophytum procumbens kanye ne-in vitro inhibition ye-leukocyte elastase yabantu. UPlanta Med 2003; 69: 820-825. Buka okungaqondakali.
  53. UClarkson, C., uCampbell, uW., NoSmith, uP. In vitro antiplasmodial activity of abietane and totarane diterpenes ehlukaniswe neHarpagophytum procumbens (devil's claw). UPlanta Med 2003; 69: 720-724. Buka okungaqondakali.
  54. U-Betancor-Fernandez, A., uPerez-Galvez, A., uSies, H., no-Stahl, W. Amalungiselelo wemithi yokuhlola aqukethe okukhishwe i-turmeric rhizome, iqabunga le-artichoke, impande ka-devil's claw nogalikhi noma uwoyela we-salmon we-antioxidant umthamo. UJ Pharm Pharmacol 2003; 55: 981-986. Buka okungaqondakali.
  55. UMunkombwe, N. M. Acetylated phenolic glycosides avela kuHarpagophytum procumbens. I-Phytochemistry 2003; 62: 1231-1234. Buka okungaqondakali.
  56. UGobel, H., Heinze, A., Ingwersen, M., Niederberger, U., noGerber, D. [Imiphumela ye-Harpagophytum ibeka i-LI 174 (uzipho lukaDeveli) ku-sensory, motor and vascular reagibility in the treatment of unspecific back ubuhlungu]. Schmerz. 2001; 15: 10-18. Buka okungaqondakali.
  57. ULaudahn, D. noWalper, A. Ukusebenza nokubekezelelana kweHarpagophytum kukhishwe i-LI 174 ezigulini ezinobuhlungu obungapheli obungemuva. I-Phytother.Res. 2001; 15: 621-624. Buka okungaqondakali.
  58. U-Loew, D., Mollerfeld, J., Schrodter, A., Puttkammer, S., noKaszkin, M. Uphenyo ngezakhi ze-pharmacokinetic zezinto ze-Harpagophytum kanye nemiphumela yazo ku-eicosanoid biosynthesis in vitro ne-ex vivo. Umtholampilo. Pharmacol. 2001; 69: 356-364. Buka okungaqondakali.
  59. ULeblan, D., Chantre, P., noFournie, B. Harpagophytum procumbens ekwelapheni i-osteoarthritis yamadolo ne-hip. Imiphumela yezinyanga ezine yesilingo esilindelekile, esinamandla amaningi, esingaboni kabili uma kuqhathaniswa ne-diacerhein. I-Bone Spine ehlangene 2000; 67: 462-467. Buka okungaqondakali.
  60. UBaghdikian, B., Guiraud-Dauriac, H., Ollivier, E., N'Guyen, A., Dumenil, G., noBalansard, G. Ukwakhiwa kwama-metabolites aqukethe i-nitrogen avela kuma-iridoid amakhulu we-Harpagophytum procumbens no-H. zeyheri ngamagciwane emathunjini omuntu. UPlanta Med 1999; 65: 164-166. Buka okungaqondakali.
  61. UChrubasik, S., Junck, H., Breitschwerdt, H., Conradt, C., noZappe, H. Ukusebenza kweHarpagophytum kukhipha i-WS 1531 ekwelapheni ukwanda kobuhlungu obuphansi emuva: ukulawulwa okungahleliwe, okulawulwa yi-placebo, kabili- ukutadisha okuyimpumputhe. U-Eur.J Anaesthesiol. 1999; 16: 118-129. Buka okungaqondakali.
  62. UGagnier, J. J., van Tulder, M., Berman, B., noBombardier, C. Umuthi wamakhambi wezinhlungu ezisezingeni eliphansi. Idatha yedatha yeCochrane. 2006; CD004504. Buka okungaqondakali.
  63. Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., noTenborg, M. Ukushintshaniswa kwenkulumo ye-cytokine ngemithi yendabuko: ukubuyekezwa kwama-immunomodulators wamakhambi. Okuhlukile.I-Med. 2006; 11: 128-150. Buka okungaqondakali.
  64. U-Ernst, E. noChrubasik, S. Phyto-anti-inflammatories. Ukubuyekezwa okuhlelekile kokuhlolwa okungahleliwe, okulawulwa yi-placebo, okuyimpumputhe kabili. I-Rheum.Dis Clin North eNyakatho Am 2000; 26: 13-27, vii. Buka okungaqondakali.
  65. URomiti N, uTramonti G, uCorti A, uChieli E. Imiphumela kaDeveli's Claw (Harpagophytum procumbens) ku-multidrug transporter ABCB1 / P-glycoprotein. I-Phytomedicine 2009; 16: 1095-100. Buka okungaqondakali.
  66. UGagnier JJ, van Tulder MW, Berman B, Bombardier C.Umuthi wamakhambi wezinhlungu ezisezingeni eliphansi. Ukubuyekezwa kukaCochrane. Isiphetho 2007; 32: 82-92. Buka okungaqondakali.
  67. UChrubasik S, Kunzel O, Thanner J, et al. Ukulandelwa konyaka ongu-1 ngemuva kocwaningo lokushayela ngeDoloteffin ngezinhlungu ezisezingeni eliphansi. I-Phytomedicine 2005; 12: 1-9. Buka okungaqondakali.
  68. I-Wegener T, iLupke NP. Ukwelashwa kweziguli ezine-arthrosis ye-hip noma idolo ngokukhishwa okunamanzi kukazipho kaDeveli (Harpagophytum procumbens DC). I-Phytother Res 2003; 17: 1165-72. Buka okungaqondakali.
  69. Unger M, uFrank A.Ukuzimisela ngasikhathi sinye kwamandla okuvimbela ukukhishwa kwamakhambi ekusebenzeni kwama-enzyme ayisithupha amakhulu e-cytochrome P450 kusetshenziswa i-chromatography / mass spectrometry ye-liquid kanye nokukhipha okuzenzakalelayo kwe-inthanethi. I-Massid Commun Mass Spectrom 2004; 18: 2273-81. Buka okungaqondakali.
  70. UJang MH, uLim S, uHan SM, et al. I-Harpagophytum procumbens icindezela izinkulumo eziphefumulelwe ze-lipopolysaccharide-cyclooxygenase-2 kanye ne-inducible nitric oxide synthase ku-fibroblast cell line L929. J Pharmacol Sci 2003; 93: 367-71. Buka okungaqondakali.
  71. UGagnier JJ, Chrubasik S, Manheimer E.Harpgophytum proumbens for osteoarthritis kanye nobuhlungu obuphansi emuva: ukubuyekezwa okuhlelekile. I-BMC Complement Altern Med 2004; 4: 13. Buka okungaqondakali.
  72. UMoussard C, u-Alber D, uToubin MM, et al. Isidakamizwa esisetshenziswa emithini yendabuko, i-harpagophytum procumbens: abukho ubufakazi bomphumela ofana ne-NSAID ekukhiqizeni lonke igazi le-eicosanoid kumuntu. I-Prostaglandins Leukot Essent Fatty Acids. 1992; 46: 283-6 .. Buka okungaqondakali.
  73. I-Whitehouse LW, iZnamirowska M, uPaul CJ. UDeveli's Claw (Harpagophytum procumbens): abukho ubufakazi bokwenza umsebenzi wokulwa nokuvuvukala ekwelapheni isifo samathambo. Ingabe iMed Assoc J 1983; 129: 249-51. Buka okungaqondakali.
  74. UFiebich BL, uHeinrich M, uHiller KO, uKammerer N. Ukuvinjelwa kwe-TNF-alpha synthesis kuma-LPS-avuselelwe ama-monocyte ayisisekelo womuntu yi-Harpagophytum ekhipha iSteiHap 69. I-Phytomedicine 2001; 8: 28-30 .. Buka okungaqondakali.
  75. UBaghdikian B, uLanhers MC, uFleurentin J, et al. Ucwaningo lokuhlaziya, imiphumela elwa nokuvuvukala kanye ne-analgesic ye-Harpagophytum procumbens ne-Harpagophytum zeyheri. UPlanta Med 1997; 63: 171-6. Buka okungaqondakali.
  76. AmaLanhers MC, uFleurentin J, uMortier F, et al. Imiphumela yokulwa nokuvuvukala kanye ne-analgesic yokukhishwa okunamanzi kwe-Harpagophytum procumbens. UPlanta Med 1992; 58: 117-23. Buka okungaqondakali.
  77. UGrahame R, uRobinson BV. Uzipho lukaDeveli (Harpagophytum procumbens): izifundo zemithi nezemitholampilo. U-Ann Rheum Dis 1981; 40: 632. Buka okungaqondakali.
  78. UChrubasik S, uSporer F, uDillmann-Marschner R, et al. Izakhiwo zomzimba ze-harpagoside kanye nokukhishwa kwayo kwe-in vitro kusuka eHarpagophytum procumbens kukhipha amaphilisi. I-Phytomedicine 2000; 6: 469-73. Buka okungaqondakali.
  79. I-Soulimani R, i-Younos C, i-Mortier F, i-Derrieu C. Indima yokugaywa kwesisu emsebenzini wezemithi wezitshalo ezikhishwe, kusetshenziswa njengesibonelo sokukhishwa kwe-Harpagophytum procumbens. Ngabe uJ Physiol Pharmacol 1994; 72: 1532-6. Buka okungaqondakali.
  80. ICosta De Pasquale R, uBusa G, et al. Isidakamizwa esisetshenziswa emithini yendabuko: IHarpagophytum procumbens DC. III. Imiphumela kuma-arrhythmias e-hyperkinetic ventricular by reperfusion. J Ethnopharmacol 1985; 13: 193-9. Buka okungaqondakali.
  81. ICircosta C, i-Occhiuto F, uRagusa S, et al. Isidakamizwa esisetshenziswa emithini yendabuko: IHarpagophytum procumbens DC. II. Umsebenzi wenhliziyo. UJ Ethnopharmacol 1984; 11: 259-74. Buka okungaqondakali.
  82. UChrubasik S, Thanner J, Kunzel O, et al. Ukuqhathaniswa kwezinyathelo zemiphumela ngesikhathi sokwelashwa ne-Harpagophytum ephathelene nokukhipha i-doloteffin ezigulini ezinobuhlungu emhlane ongezansi, edolweni noma okhalweni. I-Phytomedicine 2002; 9: 181-94. Buka okungaqondakali.
  83. UBarak AJ, Beckenhauer HC, uTuma DJ. I-Betaine, i-ethanol, nesibindi: isibuyekezo. Utshwala 1996; 13: 395-8. Buka okungaqondakali.
  84. UChantre P, uCappelaere A, uLeblan D, et al. Ukusebenza nokubekezelelana noma iHarpagophytum procumbens kuqhathaniswa ne-diacerhein ekwelapheni i-osteoarthritis. I-Phytomedicine 2000; 7: 177-83. Buka okungaqondakali.
  85. UFetrow CW, u-Avila JR. IProfessional’s Handbook of Complementary & Alternative Medicines. 1st ed. ISpringhouse, PA: ISpringhouse Corp., 1999.
  86. UKrieger D, uKrieger S, uJansen O, et al. I-Manganese ne-chronic hepatic encephalopathy. ILancet 1995; 346: 270-4. Buka okungaqondakali.
  87. Shaw D, Leon C, Kolev S, Murray V. Amakhambi wendabuko kanye nezithako zokudla: isifundo seminyaka emihlanu yobuthi (1991-1995). Izidakamizwa Saf 1997; 17: 342-56. Buka okungaqondakali.
  88. Ukuphikiswa kukaBrinker F. Herb nokusebenzisana kwezidakamizwa. Okwesibili. USandy, NOMA: I-Eclectic Medical Publications, 1998.
  89. Wichtl MW. Izidakamizwa ze-Herbal kanye ne-Phytopharmaceuticals. Umhleli. UNM Bisset. Stuttgart: IMedpharm GmbH Scientific Publishers, 1994.
  90. INewall CA, Anderson LA, uPhilpson JD. Herbal Medicine: Umhlahlandlela Wongoti Bezempilo. ILondon, e-UK: I-Pharmaceutical Press, ngo-1996.
Kugcine ukubuyekezwa - 05/06/2020

Imibhalo Ye-Portal

Ukuvimbela unhlangothi
Umuthi

Ukuvimbela unhlangothi

I ifo ohlangothi enzeka lapho ukugeleza kwegazi kunqamulelwa kunoma iyiphi ingxenye yobuchopho. Ukwehla kokugeleza kwegazi kungadalwa yihlule legazi emthanjeni wobuchopho. Kungabangelwa futhi yi it ha...
Salsalate
Umuthi

Salsalate

Abantu abathatha imi hanguzo yokulwa nokuvuvukala (ama-N AID) (ngaphandle kwama-a pirin) afana ne- al alate bangaba nengozi enkulu yokuhla elwa yi ifo enhliziyo noma i ifo ohlangothi kunabantu abangay...